ID   201B3
AC   CVCL_A064
SY   201-B3; KUIFMSi004-E
DR   hPSCreg; KUIFMSi004-E
DR   ISCR; 36
DR   SKIP; SKIP001162
DR   SKIP; SKIP002371
DR   Wikidata; Q54583060
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,14
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 28
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 8,10
ST   Penta E: 7,19
ST   TH01: 5
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 16
//
RX   PubMed=18035408; DOI=10.1016/j.cell.2007.11.019;
RA   Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K.,
RA   Yamanaka S.;
RT   "Induction of pluripotent stem cells from adult human fibroblasts by
RT   defined factors.";
RL   Cell 131:861-872(2007).
//